FDA and AI: The Agency’s Evolving Policies on AI and Related Technologies for, and Its Own Growing Use of AI in Regulating, Medical Products
| Tuesday, September 29, 2026 |
| 02:00 PM - 03:00 PM Eastern Daylight Time |
| 01:00 PM - 02:00 PM Central Daylight Time |
| 11:00 AM - 12:00 PM Pacific Daylight Time |
This webinar will discuss the FDA’s policies on the use of artificial intelligence and related technologies for pharmaceutical and medical device development and operations, regulations regarding health-related uses of AI, and other recent developments, including the growth and expansion of FDA’s own use of AI in regulating medical products.
CLE CREDIT
CLE credit in CA, FL, IL, NY*, PA, TX, VA, and WA is currently pending approval; credit in CT and NJ is pending approval (via reciprocity). CLE credit is not available for the viewing of recorded sessions.
*This program qualifies for Newly Admitted Attorneys.
Those seeking CLE credit in any other state may be provided with a General Certificate of Attendance and may apply independently.
CLE Questions?
Please contact CLECreditRequest@morganlewis.com.